Stories from 2020
UHB part of global trial leading to first COVID-19 treatment drug
UHB patients involved in study which identified the first successful treatment option for some coronavirus patients.
Liver perfusion could save 7 in 10 rejected donor livers
Major liver perfusion study shows up to 7 in every 10 rejected donor livers could be used after just 4 – 6 hours.
First drugs announced in major COVID-19 trial
Two UK drugs companies partner with Birmingham and Oxford universities to test potential therapeutic COVID-19 treatment.
Gene study explores varying effect of COVID-19
UHB joins the fight against coronavirus by recruiting COVID-19 patients to participate in a ground-breaking new study.
Major COVID-19 drugs trial begins in Birmingham
A trial to rapidly test new therapies for patients hospitalised due to COVID-19 is opening in Birmingham this week.
Prioritising COVID-19 Research
UHB is taking part in a number of national trials that are rapidly investigating potential treatments for COVID-19.